Pharmacy

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Bayer submits marketing authorization applications for finerenone in the U.S. and the EU

The FINANCIAL — Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) seeking approval of finerenone for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Finerenone is

by The FINANCIAL

November 10, 2020

1 min read

Pharmacy

AstraZeneca’s Calquence approved in the EU for the treatment of most common type of leukaemia in adults

The FINANCIAL — AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union (EU) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL), the most common type of leukaemia in adults. The approval

by The FINANCIAL

November 9, 2020

4 mins read

Pharmacy

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

The FINANCIAL — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischaemic attack

by The FINANCIAL

November 6, 2020

1 min read

Pharmacy

Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer

The FINANCIAL — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the China National Medical Products Administration (NMPA) has approved XTANDI® (enzalutamide soft capsules) for the treatment of adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) with high

by The FINANCIAL

November 6, 2020

2 mins read

Pharmacy

Roche to present new data across 16 blood disorders at the ASH 2020 Annual Meeting

The FINANCIAL — Roche today announced that new data for its approved and investigational medicines will be presented at the all-virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition from 5 – 8 December 2020. Eleven Roche medicines will be

by The FINANCIAL

November 5, 2020

3 mins read

Pharmacy

EU approved AstraZeneca’s Forxiga for heart failure

The FINANCIAL — AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes (T2D). Heart failure (HF) is a life-threatening chronic disease that

by The FINANCIAL

November 5, 2020

1 min read

Pharmacy

Bayer reported sales decrease by 5.1%

The FINANCIAL — Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.) to 8.506 billion euros / EBITDA before special items falls 21.4 percent to 1.795 billion euros / Substantial decline in sales and

by The FINANCIAL

November 3, 2020

7 mins read

Pharmacy

EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer

The FINANCIAL — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior

by The FINANCIAL

November 2, 2020

2 mins read

Pharmacy

AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm

The FINANCIAL — AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in around 70 countries globally to Cheplapharm Arzneimittel GmbH (Cheplapharm). Atacand is a prescription medicine approved for the treatment of heart failure

by The FINANCIAL

October 30, 2020

1 min read

Pharmacy

Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates

The FINANCIAL – Novo Nordisk published financial report for the period 1 January 2020 to 30 September 2020 Sales increased by 6% in Danish kroner and by 7% at CER to DKK 94.8 billion. Sales in International Operations increased by 9% in

by The FINANCIAL

October 30, 2020

1 min read

1 2 3 … 195 Next

Pharmacy

Roche ranked the most sustainable healthcare company in the DJSI

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

Bayer submits marketing authorization applications for finerenone in the U.S. and the EU

AstraZeneca’s Calquence approved in the EU for the treatment of most common type of leukaemia in adults

FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke

Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer

Roche to present new data across 16 blood disorders at the ASH 2020 Annual Meeting

EU approved AstraZeneca’s Forxiga for heart failure

Bayer reported sales decrease by 5.1%

EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer

AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm

Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pharmacy

Popular Posts

Recent Posts

Get updates

Join

Latest comments